Working… Menu
Trial record 5 of 14 for:    22186789 [PUBMED-IDS]

Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02639234
Recruitment Status : Withdrawn
First Posted : December 24, 2015
Last Update Posted : July 31, 2017
Information provided by (Responsible Party):
Gradalis, Inc.

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Estimated Primary Completion Date : March 2017
Actual Study Completion Date : March 2017